End The NBA Lockout, Before Desmond Mason Films This Shitty Movie
I know he's not technically an active player anymore, but still - he might try to work out for a 10-day-contract instead of this.
But let's step back a second. We don't know that it'll be a shitty movie. Maybe it'll be great, and Mason will conquer celluloid like he could never dominate the hardwood. Let's read a recap before we pass judgment.
"Just Crazy Enough" is a family-friendly comedy about identical twins separated at birth. According to the film's website, one twin becomes a prominent psychiatrist and the other a lifelong mental patient. The psychiatrist ends up swapping places with a twin he knows nothing about.
Former "Saturday Night Live" cast member Chris Kattan will play the lead role.
OK, it's gonna be shitty.
Mason says his role will be "pretty big," a character who "speaks only in cliches and won't hold a normal conversation with anyone." So, a pro athlete, basically.
How did Mason get the job? Apparently he's an accomplished artist, and was asked to design an award for an Oklahoma City film festival. That festival's executive director is the one making "Just Crazy Enough." This is how the business works, people. Ten years in the NBA, and for what? The chance to make Chris Kattan look good?
Desmond Mason goes from slam dunks to silver screen [Tulsa World]
WNBA Overreacted to Angel Reese and Paige Bueckers’ $400 Bet
Ohio State Reloads for 2026 With Brutal Schedule Ahead
Vita Vea Requests Trade, and the Rams Make Too Much Sense
WNBA Picks Tuesday: Best Bets for Lynx, Fever and Aces
- MLB Best Bets for Sunday's Rockies vs. Brewers, Yankees vs. Phillies
- UFC Abu Dhabi Best Bets: Top Picks for Ankalaev vs. Guskov Fight Night
- WNBA All-Star Weekend Best Bets: Caitlin Clark, Marina Mabrey and More
- MLB Player Props Today: Best Bets for Wednesday, July 22
- WNBA Best Bets: Wednesday Picks Featuring Lynx, Aces and Wings
- Twins vs. Guardians Prediction: Best Bets for Tuesday's AL Central Showdown
- MLB Best Bets: Jacob Misiorowski, Dylan Cease Lead Monday's Top Picks

